Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Rapamycin
Related studies linked through entity extraction aliases.
Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease
- Status
- COMPLETED
- Phase
- PHASE1
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia
- Status
- COMPLETED
- Phase
- N/A
Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial
- Status
- COMPLETED
- Phase
- PHASE1
Topical Rapamycin to Erase Angiofibromas in TSC
- Status
- COMPLETED
- Phase
- PHASE2
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
- Status
- COMPLETED
- Phase
- NA
Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens
- Status
- COMPLETED
- Phase
- PHASE4
Pre Transplant Rapamycin Treatment in Islet Transplantation Alone
- Status
- COMPLETED
- Phase
- PHASE3
Rapamycin and Regulatory T Cells in Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Topical Rapamycin for Fibrofolliculomas
- Status
- COMPLETED
- Phase
- PHASE3
Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Nutritional and Contractile Regulation of Muscle Growth
- Status
- COMPLETED
- Phase
- PHASE1
Rapamycin in Relapsed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Study of Rapamycin for the Treatment of SLE
- Status
- COMPLETED
- Phase
- PHASE2